News Pfizer axes Alzheimer's and Parkinson's research Big pharma will continue developing tanezumab painkiller with Lilly
Views & Analysis Looking back, looking forward – Janssen’s 60 years on the ps... Improving targeted treatments and partnering on initiatives to reduce stigma and support mental health patients.
News Takeda retains UK investment with new neuroscience company C... Takeda joins with venture capital group to fund neuroscience research
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.